Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma
Clinical trial NCT02678572 · COMPLETED
Trial details
- NCT number
- NCT02678572
- Sponsor
- Delcath Systems Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2023-05-18
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.